Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 19/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2795891 | 1.00 | TLR4 (0.50) | TLR4SELP | |
| SCHEMBL2796027 | 0.96 | TLR4 (0.52) | TLR4SELP | |
| SCHEMBL2794172 | 0.96 | TLR4 (0.49) | TLR4SELP | |
| SCHEMBL2796372 | 0.94 | TLR4 (0.55) | TLR4SELP | |
| SCHEMBL2796375 | 0.94 | TLR4 (0.55) | TLR4SELP | |
| SCHEMBL2797999 | 0.94 | TLR4 (0.48) | TLR4SELP | |
| SCHEMBL2798002 | 0.94 | TLR4 (0.48) | TLR4SELP | |
| SCHEMBL2792462 | 0.93 | TLR4 (0.48) | TLR4SELP | |
| SCHEMBL2792460 | 0.93 | TLR4 (0.48) | TLR4SELP | |
| SCHEMBL18789816 | 0.93 | TLR4 (0.57) | TLR4SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130035479-A1 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | OM PHARMA (CH) | 2013-02-07 | — | — | US | disclosed |
| US-20100168054-A1 | Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation | OM PHARMA (CH) | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035479-A1 | FUNCTIONALIZED BETA 1,6 GLUCOSAMINE DISACCHARIDES AND PROCESS FOR THEIR PREPARATION | FUT6, FUT5, B3GNT2 | TLR4 748/4885SELP 1265/4885 |
| US-20100168054-A1 | Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation | FUT6, FUT5, B3GNT2 | TLR4 748/4885SELP 1265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.